Skip to content
value.today
Brainsway Ltd. logo

Brainsway Ltd.

Brainsway Ltd. is listed today as BrainsWay Ltd.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Brainsway Ltd.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2024$20 MPrivate placement after listing$10 to $50 million

Brainsway Ltd.: Private sale, Sep 2024

Investors in this round

1 investor had bought by the notice of Oct 15, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Israel

People named in the notice

  • Hadar Levy · Executive Officer · Chief Executive Officer
  • Ido Marom · Executive Officer · Chief Financial Officer
  • Abraham Zangen · Director
  • Ami Boehm · Director · Chairman of the Board of Directors
  • Avner Hagai · Director
  • Avner Lushi · Director
  • David Zacut · Director · Vice Chairman of the Board of Directors
  • Eti Mitrany · Director
  • Karen Sarid · Director
  • Yossi Ben Shalom · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This Form D is being filed in connection with the issuance of 2,103,745 ADSs, each representing two ordinary shares of the Company, at a purchase price of $9.50686 per ADS and a warrant to purchase 1,500,000 ADSs at an exercise price of $9.50686 per ADS.”

Signed by Hadar Levy, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 15, 2024. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Brainsway Ltd. chose not to state its revenue in its newest notice of a funding round (Oct 2024).

    SEC Form D · Oct 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2024

That is all the official record says: Brainsway Ltd. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Brainsway Ltd. are on record.

Investors#

No investor of Brainsway Ltd. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.

Largest shareholders today

Institutions holding BrainsWay Ltd. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Brainsway Ltd.
NameRoleNamed in
Hadar LevyChief Executive OfficerOct 2024
Ido MaromChief Financial OfficerOct 2024
Abraham ZangenDirectorOct 2024
Ami BoehmChairman of the Board of DirectorsOct 2024
Avner HagaiDirectorOct 2024
Avner LushiDirectorOct 2024
David ZacutVice Chairman of the Board of DirectorsOct 2024
Eti MitranyDirectorOct 2024
Karen SaridDirectorOct 2024
Yossi Ben ShalomDirectorOct 2024

About

Medical technology company.

Went public since 2019. Its SEC number is that of a company listed on a stock exchange.